Contact urticaria syndrome from eye drops: Levofloxacin hydrate ophthalmic solution

Journal of Dermatology

Volumn 40, Issue 2, 2013, Pages 130-131

  Saito, Miho ^a   Nakada, Tokio ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE SODIUM PHOSPHATE; EYE DROPS; LEVOFLOXACIN;

ADULT; CASE REPORT; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; CONTACT URTICARIA; CONTROLLED STUDY; DYSPNEA; FACE EDEMA; FEMALE; HUMAN; LETTER; LIMB; PRICK TEST; PRURITUS; RHINORRHEA; SNEEZING; TRUNK;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LEVOFLOXACIN; OPHTHALMIC SOLUTIONS; URTICARIA;

EID: 84874106630     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12019     Document Type: Letter

References (4)

1. Lachapelle J, Maibach H,. The methodology of open (non-prick) testing, prick testing, and its variants. In:, Lachapelle J, Maibach H, eds. Patch Testing and Prick Testing, 2nd edn. Berlin: Springer, 2009; 141-152.
2. Maibach HI, Johnson HL,. Contact urticaria syndrome. Contact urticaria to diethyltoluamide (immediate-type hypersensitivity). Arch Dermatol 1975; 111: 726-730.
3. Lachapelle J, Maibach H,. The spectrum of diseases for which prick testing and open (non-prick) testing are recommended/Patients who should be investigated. In:, Lachapelle J, Maibach H, eds. Patch Testing and Prick Testing, 2nd edn. Berlin: Springer 2009: 131-140.
4. Santen Pharmaceutical Co. Ltd. Cravit® Ophthalmic Solution 0.5%. Osaka: Santen Pharmaceutical Co. Ltd., 2007.